LAF237

· Novartis

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LAF237, covering 2012-05-02 to 2016-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects [Phase 3]